Cardinal Health — Aug 11, 2026 release

Other segment profit increased 14% to $183 million in the fourth quarter, driven by growth in OptiFreight Logistics and at-Home Solutions. Cardinal Health Page 3 Fiscal year 2027 outlook 2 The company released its fiscal year 2027 outlook for non-GAAP diluted EPS of +13% to +15% growth 3 ($12.40 to $12.60). Non-GAAP earnings per share $12.40 to $12.60 Pharmaceutical and Specialty Solutions segment: Revenue 3% to 5% growth Segment profit 8% to 11% growth Global Medical Products and Distribution segment: Revenue 2% to 4% growth Segment profit $200 million to $220 million Other (NPHS, at-Home Solutions, OptiFreight Logistics): Revenue 11% to 13% growth Segment profit 15% to 18% growth Interest and other $240 million to $290 million Non-GAAP effective tax rate 19.0% to 20.0% Diluted weighted average shares outstanding ~233 million Share repurchases ~$1 billion Capital Expenditures ~$700 million Non-GAAP adjusted free cash flow $3.5 billion to $4.0 billion Financial guidance for fiscal year 2027 reflects the estimated impact of the Company’s recently completed tuck-in acquisition of Strive Medical and the announced tuck-in acquisition of the Diabetes Health business of AdaptHealth. Recent highlights • Cardinal Health recently completed an additional $350 million accelerated share repurchase program, bringing year-to-date share repurchases in fiscal year 2026 to $1.4 billion • Cardinal Health Board of Directors approved a $5.0 billion increase to the share repurchase program, bringing the total share repurchase authorization to $6.4